Technology | Clinical Decision Support | March 16, 2017

IBM Watson Health to Integrate MedyMatch Technology into Cognitive Imaging Offerings

MedyMatch application to help doctors identify head trauma and stroke

March 16, 2017 — MedyMatch Technology announced a collaboration with IBM  Watson Health to bring MedyMatch’s artificial intelligence (AI)-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings. In this application, the technology can help doctors identify instances of intracranial bleeding as a result of head trauma and stroke.

Initially, IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channels. Moving forward, IBM Watson Health and MedyMatch will develop interoperability between MedyMatch’s application and IBM Watson Health Imaging’s offerings.

According to the American Heart Association and American Stroke Association (AHA/ASA), stroke is the fourth leading cause of death and one of the top causes of preventable disability in the United States. Affecting 4 percent of U.S. adults, it is forecasted that by 2030, there will be approximately 3.4 million stroke victims annually in the U.S., costing the healthcare system $240 billion on an annual basis.

MedyMatch aims to bring cognitive tools into the daily workflow of an emergency department to help physicians assess patients suspected of head trauma or stroke, and rule out the presence of a bleed in the brain. The MedyMatch algorithm uses sophisticated deep learning, machine vision, patient data and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds — and does so without interrupting how a physician works.   

“The implementation of AI-based computer-aided detection and clinical decision support tools to medicine in general, and to the emergency department in particular, has the potential to increase the speed, accuracy and efficiency of patient management – with the potential to ultimately reduce diagnostic errors and improving clinical outcomes,” said Michael Lev, M.D., director of emergency radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School.  “MedyMatch is ideally positioned to leverage this technology, and their willingness to collaborate with industry partners reflects their awareness of, and sensitivity to, the complexities of patient assessment in the acute care setting.  The company’s first algorithms — CT [computed tomography] detection of intracranial bleeds — represents the confluence of physician know-how and artificial intelligence clinical support.”

MedyMatch is currently conducting a clinical trial for its intracranial bleed assessment application and is working towards a PMA (premarket approval) Class III approval by the U.S. Food and Drug Administration (FDA).

For more information: www.medymatch.com, www.ibm.com/watsonhealth

Related Content

Enhancing Patient Care Inspires Southwest Medical Center to Upgrade to Enterprise Imaging

Assad Zainali, M.D., and Kelly Denton, director of imaging at Southwest Medical Center, review radiology studies with Novarad's Ncompass Enterprise Imaging.

Sponsored Content | Case Study | Enterprise Imaging | April 18, 2018
Southwest Medical Center (SWMC) serves patients from Kansas, Oklahoma, Colorado, New Mexico and Texas. Since seeing its...
Roper Radiologists PA Adapted an Interactive, Dynamic Worklist to Orchestrate and Measure Workflow

Matthew Brady, M.D.

Sponsored Content | Case Study | PACS Accessories | April 18, 2018
Matthew Brady, M.D., a radiologist at Roper Radiologists PA in Charleston, S.C., addresses the often-interwoven topics...
MACRA Implications for Payers, Providers and EHR Systems
Feature | Radiology Business | April 18, 2018 | Christopher Emper
For better or worse, the Medicare Access, CHIP Reauthorization Act (MACRA) is expected to disrupt healthcare at every
What It's Going to Take for AI to go Mainstream

Image courtesy of Pixabay

Feature | Artificial Intelligence | April 18, 2018 | Paddy Padmanabhan
No technology concept is going to be more discussed, dissected or debated in healthcare this year than artificial int
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Chest X-ray AI Algorithm Correctly Identifies Lung Disease for Dubai Health Authority
Feature | Artificial Intelligence | April 17, 2018
The Dubai Health Authority (DHA) announced the preliminary results of a chest X-ray artificial intelligence (AI)...
Philips Warns of Cybersecurity Vulnerabilities in IntelliSpace and iSite PACS Products
News | Cybersecurity | April 16, 2018
Philips Healthcare last week issued a proactive advisory warning to its iSite and IntelliSpace picture archiving and...
Dicom Systems Installs First Enterprise Imaging Platform in Africa
News | Enterprise Imaging | April 12, 2018
Dicom Systems Inc. recently announced it has deployed its flagship Workflow Unifier platform at the foot of Mount...
Healthcare Administrative Partners Launches Deep Dive Analytics Service
Technology | Analytics Software | April 12, 2018
Healthcare Administrative Partners (HAP) announced the launch of Deep Dive Analytics, an integrated clinical data...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Overlay Init